Trial intelligence / Profile preview

Perioperative intravenous lignocaine pharmacokinetics in bariatric and non-bariatric laparoscopic abdominal surgery

ACTRN12618001658202Phase 4Recruiting

Sponsor
RBWH Anaesthetic Department
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of lidocaine in obesity, sponsored by RBWH Anaesthetic Department. Primary endpoint: Plasma lignocaine levels. Started Jun 2019; status: recruiting.

02

Drugs

lidocaine
03

Conditions

obesity

Beyond the preview

Go deeper on ACTRN12618001658202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618001658202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call